Patents by Inventor M. Beckmann

M. Beckmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods of using flt3-ligand in the treatment of cancer
    Publication number: 20070207164
    Abstract: Ligands for flt3 receptors capable of transducing self-renewal signals to regulate the growth, proliferation or differentiation of progenitor cells and stem cells are disclosed. The invention is directed to Flt3-ligand as an isolated protein, the DNA encoding the Flt3-ligand, host cells transfected with cDNAs encoding Flt3-ligand, compositions comprising Flt3-ligand and methods of using Flt3-ligand in hematopoietic cell transplantation.
    Type: Application
    Filed: June 8, 2006
    Publication date: September 6, 2007
    Inventors: Stewart Lyman, M. Beckmann
  • Glycoproteins which bind to TNF
    Publication number: 20060067934
    Abstract: Tumor necrosis factor receptor DNAs and expression vectors encoding TNF receptors, and processes for producing TNF receptors as products of recombinant cell culture, are disclosed.
    Type: Application
    Filed: October 28, 2005
    Publication date: March 30, 2006
    Inventors: Craig Smith, Raymond Goodwin, M. Beckmann
  • Antibodies to interleukin-4 receptors and uses thereof
    Publication number: 20050118176
    Abstract: Mammalian Interleukin-4 receptor proteins, DNAs and expression vectors encoding mammalian IL-4 receptors, and processes for producing mammalian IL-4 receptors as products of cell culture, are disclosed. A method for suppressing an IL-4-dependent immune or inflammatory response in a mammal, including a human, by administering an effective amount of soluble IL-4 receptor (sIL-4R) and a suitable diluent or carrier.
    Type: Application
    Filed: October 17, 2003
    Publication date: June 2, 2005
    Inventors: Bruce Mosley, David Cosman, Linda Park, M. Beckmann, Carl March, Rejean Idzerda
  • Methods of using Flt3-Ligand in hematopoietic cell transplantation procedures incorporating nonmyeloablative conditioning regimens
    Publication number: 20050058622
    Abstract: The invention is directed to methods of using Flt3-Ligand in hematopoietic cell transplantation procedures using nonmyeloablative conditioning regimens. This abstract is provided for the sole purpose of enabling the reader to quickly ascertain the subject matter of the technical disclosure and is not intended to be used to interpret or limit the scope or meaning of the claims.
    Type: Application
    Filed: December 8, 2003
    Publication date: March 17, 2005
    Inventors: Stewart Lyman, M. Beckmann, Hilary McKenna, Richard Nash